Skip to main content
. Author manuscript; available in PMC: 2016 Oct 6.
Published in final edited form as: Int J Tuberc Lung Dis. 2014 Jun;18(6):694–699. doi: 10.5588/ijtld.13.0807

FIGURE 1.

FIGURE 1

Distribution of ART eligibility, expected timing of ART initiation, and observed timing of ART initiation in 492 patients receiving integrated TB and HIV treatment at five primary care clinics in Kinshasa, Democratic Republic of Congo.*

TB=tuberculosis; ART=antiretroviral therapy; CD4=CD4 count in cells/mm3; shading=delayed ART; median (IQR)=median and interquartile range of time to ART initiation from TB treatment start. *Expected timing of ART is at 1 month or 2 months from the start of TB treatment or at completion of TB treatment with a +5 day window around these timepoints to accommodate scheduling limitations, clinic closure on weekends and holidays, and on-site availability of consulting physician.